Rinvoq ER 30 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F9Q4H
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,460
Award facts
- Contract value 100% obligated
- $26,459.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 30, 2025, for the supply of RINVOQ ER 30 mg tablets in quantities of 30 units. This $26,459.60 firm fixed-price delivery order, with an ultimate completion date of December 31, 2025, is part of AmerisourceBergen's broader pharmaceutical supply relationship with DLA and represents a non-competitive, non-set-aside award. The pharmaceutical product will be delivered to AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major healthcare solutions provider supporting federal medical procurement.
This delivery order executes under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs and other federal customers including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's consistent receipt of competitively awarded federal contracts across multiple therapeutic domains demonstrates its critical role in sustaining the pharmaceutical supply chain for Department of Defense and federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F9Q4H?
SPE2DR26F9Q4H was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 30, 2025.
How much is contract SPE2DR26F9Q4H worth?
The government has obligated $26,460 on SPE2DR26F9Q4H.
Is contract SPE2DR26F9Q4H an order under another contract?
Yes. SPE2DR26F9Q4H is a delivery order under SPE2DR25D3020, an indefinite delivery contract.
Was contract SPE2DR26F9Q4H competed?
The extent of competition for SPE2DR26F9Q4H was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award